Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06678841 · ClinicalTrials.gov registry record · NA
ELEVATE-HFpEF Clinical Study
A NA study of Heart Failure With Preserved Ejection Fraction (HFPEF), sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Recruiting
- Registry status
- NA
- Development phase
- 700
- Enrollment target
- 20
- Study locations
NCT06678841 is a NA study of Heart Failure With Preserved Ejection Fraction (HFPEF) that is actively recruiting participants, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 700 participants, above the 142-participant average among 9 other Heart Failure With Preserved Ejection Fraction (HFPEF) trials with a reported enrollment target (393% higher). The trial reports 20 study locations across 17 states.
The verdict
NCT06678841, a NA study of Heart Failure With Preserved Ejection Fraction (HFPEF), is actively recruiting participants, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- RECRUITING
- Registry status
- NA
- Development phase
- 700 participants
- Enrollment target
- 20
- Study locations
Study Summary
ELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy of dual chamber personalized pacing compared to minimal or no pacing for the treatment of patients with heart failure with preserved ejection fraction (HFpEF).
Conditions Studied
Interventions
- DEVICE Personalized cardiac pacing
Study Locations (20)
Other
- Ordensklinikum Linz GmbH / Elisabethinen - Linz
- Universitair Ziekenhuis Antwerpen - Edegem
- Centre Hospitalier Universitaire Besancon - Hôpital Jean Minjoz - Besançon
Ohio
- The Ohio State University Wexner Medical Center - Columbus
- Mount Carmel East - Columbus
Connecticut
- Hartford Hospital - Hartford
Florida
- Cardiovascular Institute of Northwest Florida - Panama City
Georgia
- Emory University - Atlanta
Iowa
- Iowa Heart Center - Des Moines
Louisiana
- Cardiovascular Institute of the South - Houma
Missouri
- Saint Lukes Mid America Heart Institute - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2025-07-09 |
| Est. Completion | 2029-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06678841
The ClinicalTrials.gov registry entry for NCT06678841 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 142-participant average among 9 other Heart Failure With Preserved Ejection Fraction (HFPEF) trials with a reported enrollment target (393% higher). The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure With Preserved Ejection Fraction (HFPEF) appearing as the primary indexed condition, and to 1 intervention - of which Personalized cardiac pacing is the first listed.
NCT06678841 reports 20 study locations spanning 17 distinct geographic areas - top geographies include Other, Ohio, Connecticut.
Frequently Asked Questions
What is clinical trial NCT06678841 about?
NCT06678841 is a clinical study titled "ELEVATE-HFpEF Clinical Study". ELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy of dual chamber personalized pacing compared to minimal or no pacing for the treatment of patients with heart failure with preserved ejection ...
What is the current status of trial NCT06678841?
This trial is currently recruiting. It is a NA study. The enrollment target is 700 participants. The study started on 2025-07-09. Estimated completion is 2029-02.
What conditions does trial NCT06678841 study?
This clinical trial studies the following conditions: Heart Failure With Preserved Ejection Fraction (HFPEF).
What interventions are being tested in trial NCT06678841?
The interventions under investigation include: Personalized cardiac pacing (DEVICE).
Who is sponsoring clinical trial NCT06678841?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06678841 being conducted?
This trial has 20 study locations across Connecticut, Florida, Georgia, Iowa, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure With Preserved Ejection Fraction (HFPEF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
RECRUITING · NA
-
Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study
ACTIVE NOT RECRUITING · NA
-
The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity
RECRUITING
-
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
RECRUITING · Phase 1
-
IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
RECRUITING · Phase 4
-
The Effect of Adiposity on Muscle and Microvascular Function in HFpEF
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.